A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

A group led by Prof. Horacio Cabral has discovered a new method to construct protein complex-based therapeutics.

Researchers sought to determine whether CAR-T therapy would be effective in patients with RRMM and light chain amyloidosis.

Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...

Immunotherapy biologics represent a transformative approach in treating cancer and infections by using biological molecules to strengthen the immune system’s response. Biologics such as monoclonal ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

Northwestern Medicine scientists have discovered a new mechanism that controls a specialized group of T-cells, known as ...

A novel CAR T-cell therapy, GCC19CART, has demonstrated activity in patients with heavily pretreated, metastatic colorectal cancer.

BHUBANESWAR: Ananta Mahakud had always envisioned a bright future for his only daughter Truptimayee. His dreams came crashing ...

Now dosing at dose expansion level of 450 million NXC-201 CAR+T cells. First cohort at 150 million CAR+T cells already successfully completed ...

Targeting T cells with ustekinumab is a potential therapeutic strategy for AAV-GN that merits additional evaluation in ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.